Follow The Filings

CI Cigna

Health Care, filed as THE CIGNA GROUP (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q2, sold by 1

  • 1 Owner
  • #81
  • Max 0.1%
  • Master 0.43%
  • $115K

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Kentucky Trust Co., Kentucky Trust). Not free-float ownership.

  1. Kentucky Trust Co. 0.06%

Who owns CI

Sorted by value, long equity only, as of 2026 Q3.

History
Kentucky Trust Co., Kentucky Trust 0.06% Hold 424 $115K History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CI insider trades
  • $1M bought by 1 insider
  • $268K sold by 1 insider outside a trading plan
  • $66.6M sold by 3 insiders under 10b5-1 plans
  1. Everett Neville See Remarks
    Planned sale
    $175K 617 shares at $284.05 11% of stake
    Traded Sep 3 Filed Sep 8
  2. Nicole S Jones See Remarks
    Planned sale
    $749K 2,677 shares at $279.61 9.4% of stake
    Traded Aug 18 Filed Aug 20
  3. Nicole S Jones See Remarks
    Planned sale
    $5.4M 19,436 shares at $276.27 42% of stake
    Traded Aug 4 Filed Aug 6
  4. Jamie G Kates Chief Accounting Officer
    Sale
    $268K 899 shares at $298.61 28% of stake
    Traded Jun 12 Filed Jun 16
  5. David Cordani CEO
    Planned sale
    $59.1M 201,878 shares at $292.82 86% of stake
    Traded May 12 Filed May 14
  6. Everett Neville See Remarks
    Planned sale
    $497K 1,719 shares at $288.91 23% of stake
    Traded Mar 2 Filed Mar 3
  7. Nicole S Jones See Remarks
    Planned sale
    $667K 2,307 shares at $288.91 6.6% of stake
    Traded Mar 2 Filed Mar 3
  8. David Cordani CEO
    Buy
    $1M 4,134 shares at $241.88 +2.7% to stake
    Traded Nov 3, 2025 Filed Nov 3, 2025
  9. Brian C Evanko See Remarks
    Planned sale
    $1.6M 5,368 shares at $300.00 9.5% of stake
    Traded Oct 3, 2025 Filed Oct 7, 2025

Also filed in the last 12 months, not counted as buying or selling: 24 stock grants, 14 share withholdings for taxes, and 7 option exercises.

Congress

9 members of Congress traded CI in the last three years: 10 buys and 19 sales. 10 members listed it in 2025 annual reports.

All Congress trades
  1. Julie Johnson D-TX-32Joint Sell $1K–$15K Sep 23, 2025 filed Aug 5
  2. Julie Johnson D-TX-32Joint Buy $1K–$15K Sep 23, 2025 filed Aug 5
  3. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  4. Jared Moskowitz D-FL-23 Sell $1K–$15K Mar 23 filed Apr 30
  5. Jared Moskowitz D-FL-23Child Sell $1K–$15K Mar 23 filed Apr 30
  6. Gilbert Ray Cisneros, Jr. D-CA-31 Sell $1K–$15K Mar 13 filed Apr 7

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
8-K 5.02
8-K 7.01,9.01
10-Q
8-K 2.02,9.01
8-K 7.01
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
8-K 5.07
SCHEDULE 13G/A —
DEF 14A
DEFA14A
SCHEDULE 13G/A —

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $195.26B $247.12B $274.9B
Gross profit * $61.46B $64.61B $59.91B
Gross margin * 31.5% 26.1% 21.8%
Net income — — $5.96B
Net margin * — — 2.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $37.35B $48.87B $47.81B
Total non-current assets * $115.41B $107.01B $110.1B
Total assets $152.76B $155.88B $157.92B
Total current liabilities $48.72B $57.98B $56.34B
Total non-current liabilities * $57.69B $56.66B $59.7B
Total equity $46.22B $41.03B $41.71B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $11.81B $10.36B $9.6B
Cash from investing -$5.17B -$2.1B -$4.41B
Cash from financing -$4.29B -$7.65B -$6.42B
Net change in cash $2.36B $0.594B -$1.2B

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.